By Bioverativ | November 6, 2017ASH 2017: Bioverativ to Present New Data on Rare Blood Disorder Programs
By Bioverativ | September 6, 2017Bioverativ, Bicycle Therapeutics Enter Research Collaboration for Rare Blood Disorders
By Bioverativ | August 24, 2017Bioverativ Forms Imaging Collaboration for Improving Joint Health Management in Hemophilia Patients